The microbiome and cancer

By B. Goodman, H. Gardner. Journal of Pathology, 2018

757 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Mechanisms and consequences of intestinal dysbiosis (2017, background): “Dysbiosis can trigger disease in the first weeks of life as observed in necrotizing enterocolitis [14], during adulthood through the promotion of colorectal cancer [15], or in elderly people as exemplified by Clostridium difficile-associated diarrhea [16].”
The Pancreatic Cancer Microbiome Promotes Oncogenesis by Induction of Innate and Adaptive Immune Suppression (2018, neutral): “Microbial dysbiosis is also being increasingly recognized for its role in oncogenesis (16, 17).”
Fusobacterium nucleatum Promotes Chemoresistance to Colorectal Cancer by Modulating Autophagy (2017, background): “, 2015) and tumor-related signaling pathways (Schwabe and Jobin, 2013).”
Human Gut Microbiota and Gastrointestinal Cancer (2018, background): “Although liver is generally considered sterile, the hepatic environment is greatly influenced by the pathogens or metabolites produced by the microbiota in the GI tract through the hepatic portal venous system [140].”